News
🇪🇺 EMA Page 19Latest pharmaceutical news, drug approvals, and EMA regulatory updates
Showing 217–228 of 341 articles
Accenture Invests in Iridius to Accelerate AI Compliance Solutions for Life Sciences Companies
2 min
Charlotte MeyerPharmaceutical Company Reports Continued Growth Momentum in Q1 2026 Sales Results
2 min
Dr. Elena RossiCumberland Pharmaceuticals Announces Strategic Integration with Apotex in Major Commercial Partnership Deal
2 min
Prof. Marcus WebbReuters Pharma EU: Key Takeaways Day 1
general · 3 min
Dr. Elena RossiTilray Brands Positioned for Major U.S. Medical Cannabis Expansion Following Historic Rescheduling
Medical Cannabis · 3 min
Dr. Hannah O'ConnorCenter for Cancer and Blood Disorders Launches CAR T-Cell Therapy Program in Maryland, Expanding Community Access
FDA · 2 min
Sofia AlvarezSamaCare Launches Industry-First Prior Authorization Performance Benchmarks for Medical Benefit Drugs
2 min
Prof. Marcus WebbRepertoire Immune Medicines Doses First Patient in RPTR-1-201 Phase 1/2 Trial for Advanced Solid Tumors
2 min
Charlotte MeyerAlpha Tau Treats First Patient with Alpha DaRT in European Pancreatic Cancer Trial ACAPELLA
Pancreatic Cancer · 4 min
Dr. Elena RossiAlpha Tau Treats First European Pancreatic Cancer Patient with Alpha DaRT in ACAPELLA Clinical Trial
2 min
Sofia AlvarezBlinatumomab Long-Term Safety Study in Pediatric Leukemia Patients Reaches Final Stage
EMA · 2 min
Dr. Amina FaroukHealthcare Third-Party Logistics Market to Double by 2034, Reaching $502.6 Billion Driven by Pharmaceutical Growth
2 min
Oliver GrantPopular topics
- Drug Approvals 1,128 articles
- Clinical Trials 634 articles
- Regulatory Updates 687 articles
- Press Releases 443 articles
- Oncology 443 articles
- Mergers & Acquisitions 105 articles
- Rare Diseases 141 articles
Explore intelligence
- Global markets Cross-region command center
- Company directory Sponsor & marketer profiles
- Drug profiles INN & regulatory status
- Clinical trials hub Stage & therapy filters
- Pipeline programs R&D intelligence
- Patent landscape US & EP IP moats
- Event calendar Congress catalysts
- Regulatory reference Submission types & pathways